Lee Danner & Bass Inc. Decreases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
Lee Danner & Bass Inc. lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Get Rating) by 0.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 75,240 shares of the biopharmaceutical company’s stock after selling 226 shares during the […]